Search

everythinglearnresearchcommunity

for

Search:↓

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

Recombinant Human Annexin A5 may help treat localized scleroderma by reducing skin thickening and inflammation.

Future research on female pattern hair loss should focus on treatment effectiveness, safety, and understanding causes.

Microneedles offer a promising, less invasive way to treat and monitor psoriasis.

Stem cell therapy shows promise for treating skin disorders.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Stem-cell therapy shows promise for skin conditions but needs more research.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

The guide helps clinicians diagnose and manage hair loss, detailing examination techniques and treatments for different types of alopecia.

Teriflunomide often causes mild to moderate hair thinning and loss in MS patients, which usually improves with or without treatment.

595 nm pulsed dye laser is a cost-effective treatment for nonmelanoma skin cancer with a low recurrence rate.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Using isotretinoin gel and minoxidil solution together effectively regrows hair in most people with patchy hair loss.

Microneedling combined with triamcinolone can safely stimulate faster hair regrowth in people with Alopecia Areata.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Pimecrolimus cream is not effective for treating alopecia areata.

New methods like nanoparticles and microneedles show promise for better skin drug delivery, especially for hair disorders.

Using a patient's own tissue for micro-grafts may effectively treat non-healing leg ulcers and relieve pain.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Intralesional betamethasone and oral hydroxychloroquine improved hair loss in a woman with frontal fibrosing alopecia.

Azelaic acid cream can effectively treat scalp hair loss.

Both Betasalic ointment and 5% minoxidil are effective and safe for treating Alopecia Areata.

Survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis need ongoing care for various long-term health problems.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.